Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by Stylesson Jun 19, 2014 11:08am

173 Views

Post# 22675236

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Climb Begins

Not a seller yet. I'm just not crazy enough to buy more.

I own enough shares from the inception of GUD to not really bother adding at these lofty levels.

Think about the poor suckers who paid + 7 dollars. they are really hurting right now.

Bullboard Posts

Showcase Minerals identifies uranium and rare earth elements in Quebec